color orado a o alto p project
play

Color orado A o ALTO P Project Data Training Data Training - PowerPoint PPT Presentation

Color orado A o ALTO P Project Data Training Data Training Objectives Understand the alarming statistics/background Discuss the population of interest and timeframe Review naming report conventions; drugs monitored in the program;


  1. Color orado A o ALTO P Project Data Training

  2. Data Training Objectives • Understand the alarming statistics/background • Discuss the population of interest and timeframe • Review naming report conventions; drugs monitored in the program; final measures and what reports to submit to CHA • Review the auditing report • Discuss the lessons learned from the Opioid Safety Pilot • Questions

  3. Alarming Statistics • Pain is the most common reason for visit to the Emergency Department (ED). • Colorado is at the center of the U.S. opioid epidemic with the 12 th highest rate of misuse and abuse of prescription opioids across all 50 states. • Four out of 10 Colorado adults admit to misuse of prescription medication: primarily pain killers. • Overdoses: Two of every three from pharmaceuticals, compared to one of three from heroin. • EDs are in a strong position to reduce opioid use in a population at high risk for misuse and abuse through alternative pain management strategies.

  4. Background

  5. Background • The United States has 10 percent of the world’s population, yet consumes more than 80 percent of the world’s opioids. • In 2010, opioid consumption was 710 Morphine milligram equivalents (MME) per person in the U.S. on a yearly basis.

  6. Background

  7. Colorado ALTO Project

  8. Population of Interest and Timeframe • Population of Interest o Emergency department patients receiving and opioid or an alternative to opioid (ALTO) administration o Adults age 18 years old to 100 years old • Timeframe o Baseline data: Three months of data collection prior to launch Example: Project launch Aug 2018, Baseline May – July 2018 • o Project data: Nine months of data collection Data submissions must start on the first of selected month • Must contain full month of data •

  9. Naming Report Conventions HospID • o CHA assigned HospID attached in Data Manual ADM or EHR • o ADM = Administrative Data o EHR = Electronic Health Record YYYYMM • o Most recent month of records Baseline • o Place in name if data is baseline o If not baseline then omit V2, V3, etc. • o Place in name if resubmitting data to Sharepoint Examples: • o 999_ADM_encounters_201805_baseline.xls o 999_EHR_201802.xls o 999_EHR_201802_V2.xls

  10. Drugs Monitored Opiates ALTOs • Buprenorphine • Ketamine • Codeine • Lidocaine nasal spray • Fentanyl nasal spray • Lidocaine IV • Hydrocodone • Lidocaine patch • Hydromorphone • Lidocaine topical • Meperidine • Toradol (ketorolac tromethamine) • Methadone • Haldol (haloperidol) • Morphine • Acetaminophen • Oxycodone • Ibuprofen • Tramadol • Bentyl (dicyclomine)

  11. Final Measures Tier 1 Tier 2 Opioids Administered per 1000 ED Opioid/ALTO Prescription Trends • • Visits Physicians ALTOs Administered per 1000 ED Visits ALTO: Opioids Prescription Ratio • • Morphine Equivalent Units (MEU) per • 1000 ED Visits

  12. Reports to Submit ADM - Total ED Visits per Month Hospital_ID Data_Start_Date Data_End_Date Total_ED_Visits 999 01/01/2016 01/31/2016 796 999 02/01/2016 02/28/2016 800 999 03/01/2016 03/31/2016 808 Filename: 999_ADM_encounters_201803.xls • EHR – Medication Administration Prov HospID PAN MRN Admin Date Med Route Dose Unit NPI Dilaudid IV .5 MG 999 ABCDEF A1B2C3 01/01/2016 Hydromorphone Intravenous 15 ML 00000 999 123456 789002 01/01/2016 Fentanyl Intravenous 35 MCG 00000 Filename: 999_EHR_201601.xls •

  13. Auditing Report Prov HospID PAN MRN Admin Date Med Route Dose Unit NPI Dilaudid IV .5 MG 999 ABCDEF A1B2C3 01/01/2016 Hydromorphone Intravenous 15 ML 00000 999 123456 789002 01/01/2016 Fentanyl IV 35 MCG 00000 Prov HospID PAN MRN Admin Date Med Route Dose Unit NPI 999 ABCDEF A1B2C3 01/01/2016 Hydromorphone IV .5 mg 00000 999 ABCDEF A1B2C3 01/01/2016 Hydromorphone IV .5 mg 00000 999 123456 789002 01/01/2016 Fentanyl IV 35 MCG 00000

  14. Lessons Learned: Opioid Safety Pilot • Understanding your Hospitals EHR ecosystem Hospital Wide EHR vs ED EHR o Building custom reports o EHR assistance or Manual? • • Identifying your role Report Writer: Auditing/Managing the data report • Data Report Creator: Creating/running data report • Clinical Data Reviewer: Auditing data for correctness • Communication/Team effort •

  15. Partners

  16. Questions? Resources www.cha.com/opioid Contact Information Dominick Kuljis, MPH CHA Health Care Research Analyst dominick.kuljis@cha.com 720.330.6057

  17. You save e lives es ev every day … … Thank y you.

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend